Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro

被引:14
作者
Perrig, M
Acosta, F
Cottagnoud, M
Gerber, CM
Täuber, MG
Cottagnoud, P [1 ]
机构
[1] Inselspital Bern, Dept Internal Med, CH-3010 Bern, Switzerland
[2] Zieglerspital Bern, Dept Internal Med, CH-3007 Bern, Switzerland
[3] Univ Bern, Inst Med Microbiol, CH-3012 Bern, Switzerland
关键词
D O I
10.1093/jac/47.5.701
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Gatifloxacin penetrated well into cerebrospinal fluid (CSF) (49 +/- 11%), measured by comparison of AUC(CSF)/AUC(serum), and showed good bactericidal activity (leading to a decrease of 0.75 +/- 0.17 log(10) cfu/mL/h) in the treatment of experimental meningitis in rabbits caused by a penicillin-resistant pneumococcal strain (MIC 4 mg/L), It was significantly more effective than the standard regimen, ceftriaxone with vancomycin, which led to a decrease of 0.53 +/- 0.17 log(10) cfu/mL/h, The addition of cefepime to gatifloxacin slightly improved the killing rates (giving a decrease of 0.84 +/- 0.14 log(10) cfu/mL/h), In vitro, synergy was demonstrated between cefepime and gatifloxacin by the chequerboard method (fractional inhibitory concentration index = 0.5) and by viable counts over 8 h.
引用
收藏
页码:701 / 704
页数:4
相关论文
共 12 条
[1]   Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro [J].
Cottagnoud, P ;
Acosta, F ;
Cottagnoud, M ;
Neftel, K ;
Täuber, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2179-2181
[2]  
DOERN GV, 1997, EMERG INFECT DIS, V5, P757
[3]  
ELIOPOULOS GM, 1996, ANTIBIOTICS LAB MED, P33
[4]   Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro [J].
Gerber, CM ;
Cottagnoud, M ;
Neftel, K ;
Täuber, MG ;
Cottagnoud, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) :63-68
[5]   Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model [J].
Gerber, CM ;
Tovar, L ;
Cottagnoud, M ;
Neftel, KA ;
Täuber, MG ;
Cottagnoud, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :249-253
[6]   Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents [J].
Hoellman, DB ;
Lin, GR ;
Jacobs, MR ;
Appelbaum, PC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) :645-649
[7]   Management of infections due to antibiotic-resistant Streptococcus pneumoniae [J].
Kaplan, SL ;
Mason, EO .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) :628-+
[8]   A STUDY OF THE GENETIC MATERIAL DETERMINING AN ENZYME ACTIVITY IN PNEUMOCOCCUS [J].
LACKS, S ;
HOTCHKISS, RD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 39 (03) :508-518
[9]  
LACRETA FP, 1999, 39 INT C ANT AG CHEM, P10
[10]   Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis [J].
Lutsar, I ;
Friedland, IR ;
Wubbel, L ;
McCoig, CC ;
Jafri, HS ;
Ng, W ;
Ghaffar, F ;
McCracken, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2650-2655